Bringing 3D printing to the pharmaceutical industry

FABRX was founded by world experts in 3D printing and pharmaceutical formulation as a spin out of University College London (UK). We are driven by a passion for advancing medicine with 3D printing. We envision a world where medical treatment is fully personalized and printed on-site in pharmacies or clinical trial units. With personalized dose, flavour, colour and multi-drug combinations, medicine is more effective and patients find it easier to take, leading to better patient outcomes.

We provide an innovative, versatile and easy-to-use platform to produce personalized medicines, revolutionising medical treatment for patients around the world.

In 2023, we launched our subsidiary company in Spain, FABRX·AI, focused on advanced software solutions for pharmaceutical 3D printing. In 2024 we launched FABRX US to focus on US growth and collaboration building. In 2024 we launched FABRX US to focus on US growth and collaboration building. Get in touch now to find out more!